lartruvo 10 mg/ml concentrat solució perfusió 1 vial 50 ml
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
imbruvica® 140mg capsula
johnson & johnson del peru s.a. - capsula - por capsula - agentes antineoplÁsicos e inmunomoduladores
imbruvica 280mg tableta recubierta
j&j productos medicos & farmaceuticos del peru s.a. - droguerÍa - tableta recubierta - por vial - - agentes antineoplÁsicos e inmunomoduladores
imbruvica 420mg tableta recubierta
j&j productos medicos & farmaceuticos del peru s.a. - droguerÍa - tableta recubierta - por tableta - - agentes antineoplÁsicos e inmunomoduladores
imbruvica 140mg tableta recubierta
j&j productos medicos & farmaceuticos del peru s.a. - droguerÍa - tableta recubierta - por vial - - agentes antineoplÁsicos e inmunomoduladores
imbruvica 560mg tableta recubierta
j&j productos medicos & farmaceuticos del peru s.a. - droguerÍa - tableta recubierta - por mililitro - - agentes antineoplÁsicos e inmunomoduladores
oralair 300 ir comprimidos sublinguales
stallergenes - polen graminea extracto alergenico - comprimido sublingual - 300 mg - polen graminea extracto alergenico 300 mg - polen de plantas
oralair inicio 100 ir/300 ir comprimidos sublinguales
stallergenes - polen graminea extracto alergenico - comprimido sublingual - 300 mg + 100 mg - polen graminea extracto alergenico 300 mg - polen de plantas
spiriva respimat 2,5 microgramos solucion para inhalacion
boehringer ingelheim international gmbh - tiotropio bromuro - soluciÓn para inhalaciÓn - 2,5 microgramos/dosis - tiotropio bromuro 2,5 microgramos - tiotropio, bromuro de,